Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies.
Saved in:
| Title: | Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies. |
|---|---|
| Authors: | Rodríguez-Otero P; Cancer Center Clínica Universidad de Navarra, Cima, Pamplona, Spain. Electronic address: paurodriguez@unav.es., Gállego Pérez-Larraya J; Department of Neurology, Clínica Universidad de Navarra, IDISNA, Pamplona, Spain., Lin Y; Department of Hematology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN., Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Mason XL; Departments of Neurological Surgery and Neurology, University of Southern California, Keck School of Medicine, Los Angeles, CA., Dhakal B; Division of Hematology, Medical College of Wisconsin, Milwaukee, WI., Jakubowiak AJ; Medicine-Hematology and Oncology, University of Chicago, Chicago, IL., Lendvai N; Johnson & Johnson, Raritan, NJ., Li H; Johnson & Johnson, Shanghai, China., Yeh TM; Johnson & Johnson, Raritan, NJ., Lee E; Johnson & Johnson, Titusville, NJ., Marquez L; Johnson & Johnson, Raritan, NJ., Sharma M; Johnson & Johnson, Raritan, NJ., Montes de Oca R; Johnson & Johnson, Spring House, PA., Wang F; Johnson & Johnson, Shanghai, China., Plaks V; Johnson & Johnson, Spring House, PA., Henry K; Johnson & Johnson, Cambridge, MA., Taraseviciute A; Johnson & Johnson, Raritan, NJ., Jethava Y; Johnson & Johnson, Raritan, NJ., Jablow L; Johnson & Johnson, Raritan, NJ., Afifi S; Johnson & Johnson, Raritan, NJ., De Braganca KC; Johnson & Johnson, Horsham, PA., Madduri D; Johnson & Johnson, Raritan, NJ., Zhu J; Legend Biotech USA Inc., Somerset, NJ., Koneru M; Legend Biotech USA Inc., Somerset, NJ., Akram M; Legend Biotech USA Inc., Somerset, NJ., Patel N; Legend Biotech USA Inc., Somerset, NJ., Cohen AD; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Santomasso BD; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Jul; Vol. 26 (7), pp. 423-435.e3. Date of Electronic Publication: 2026 Apr 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42161729 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rodríguez-Otero+P%22">Rodríguez-Otero P</searchLink>; Cancer Center Clínica Universidad de Navarra, Cima, Pamplona, Spain. Electronic address: paurodriguez@unav.es.<br /><searchLink fieldCode="AU" term="%22Gállego+Pérez-Larraya+J%22">Gállego Pérez-Larraya J</searchLink>; Department of Neurology, Clínica Universidad de Navarra, IDISNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Department of Hematology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Dietrich+J%22">Dietrich J</searchLink>; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22van+de+Donk+NWCJ%22">van de Donk NWCJ</searchLink>; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mason+XL%22">Mason XL</searchLink>; Departments of Neurological Surgery and Neurology, University of Southern California, Keck School of Medicine, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Dhakal+B%22">Dhakal B</searchLink>; Division of Hematology, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Jakubowiak+AJ%22">Jakubowiak AJ</searchLink>; Medicine-Hematology and Oncology, University of Chicago, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Lendvai+N%22">Lendvai N</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Johnson & Johnson, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yeh+TM%22">Yeh TM</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Lee+E%22">Lee E</searchLink>; Johnson & Johnson, Titusville, NJ.<br /><searchLink fieldCode="AU" term="%22Marquez+L%22">Marquez L</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Sharma+M%22">Sharma M</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Montes+de+Oca+R%22">Montes de Oca R</searchLink>; Johnson & Johnson, Spring House, PA.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Johnson & Johnson, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Plaks+V%22">Plaks V</searchLink>; Johnson & Johnson, Spring House, PA.<br /><searchLink fieldCode="AU" term="%22Henry+K%22">Henry K</searchLink>; Johnson & Johnson, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Taraseviciute+A%22">Taraseviciute A</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Jethava+Y%22">Jethava Y</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Jablow+L%22">Jablow L</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Afifi+S%22">Afifi S</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22De+Braganca+KC%22">De Braganca KC</searchLink>; Johnson & Johnson, Horsham, PA.<br /><searchLink fieldCode="AU" term="%22Madduri+D%22">Madduri D</searchLink>; Johnson & Johnson, Raritan, NJ.<br /><searchLink fieldCode="AU" term="%22Zhu+J%22">Zhu J</searchLink>; Legend Biotech USA Inc., Somerset, NJ.<br /><searchLink fieldCode="AU" term="%22Koneru+M%22">Koneru M</searchLink>; Legend Biotech USA Inc., Somerset, NJ.<br /><searchLink fieldCode="AU" term="%22Akram+M%22">Akram M</searchLink>; Legend Biotech USA Inc., Somerset, NJ.<br /><searchLink fieldCode="AU" term="%22Patel+N%22">Patel N</searchLink>; Legend Biotech USA Inc., Somerset, NJ.<br /><searchLink fieldCode="AU" term="%22Cohen+AD%22">Cohen AD</searchLink>; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Santomasso+BD%22">Santomasso BD</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2026 Jul; Vol. 26 (7), pp. 423-435.e3. <i>Date of Electronic Publication: </i>2026 Apr 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42161729 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2026.04.013 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 423 Titles: – TitleFull: Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rodríguez-Otero P – PersonEntity: Name: NameFull: Gállego Pérez-Larraya J – PersonEntity: Name: NameFull: Lin Y – PersonEntity: Name: NameFull: Dietrich J – PersonEntity: Name: NameFull: van de Donk NWCJ – PersonEntity: Name: NameFull: Mason XL – PersonEntity: Name: NameFull: Dhakal B – PersonEntity: Name: NameFull: Jakubowiak AJ – PersonEntity: Name: NameFull: Lendvai N – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: Yeh TM – PersonEntity: Name: NameFull: Lee E – PersonEntity: Name: NameFull: Marquez L – PersonEntity: Name: NameFull: Sharma M – PersonEntity: Name: NameFull: Montes de Oca R – PersonEntity: Name: NameFull: Wang F – PersonEntity: Name: NameFull: Plaks V – PersonEntity: Name: NameFull: Henry K – PersonEntity: Name: NameFull: Taraseviciute A – PersonEntity: Name: NameFull: Jethava Y – PersonEntity: Name: NameFull: Jablow L – PersonEntity: Name: NameFull: Afifi S – PersonEntity: Name: NameFull: De Braganca KC – PersonEntity: Name: NameFull: Madduri D – PersonEntity: Name: NameFull: Zhu J – PersonEntity: Name: NameFull: Koneru M – PersonEntity: Name: NameFull: Akram M – PersonEntity: Name: NameFull: Patel N – PersonEntity: Name: NameFull: Cohen AD – PersonEntity: Name: NameFull: Santomasso BD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 26 – Type: issue Value: 7 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |